Skip to main content
. 2015 Jan 8;26(3):1203–1212. doi: 10.1007/s00198-014-2971-3

Fig. 3.

Fig. 3

Cumulative fracture incidence following teriparatide initiation, stratified by teriparatide persistence, and baseline antiresorptive use or fracture